Aurobindo, Hetero, and Vivimed Class Action Settlements in Kansas

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to Kansas residents.

Kansas residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for Kansas residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in Kansas

Kansas residents affected by the $15.2 million Valsartan, Losartan and Irbesartan class action settlement involving Aurobindo, Hetero, and Vivimed pharmaceutical companies should understand their rights under Kansas consumer protection laws. The Kansas Consumer Protection Act provides additional remedies for deceptive trade practices, which may complement federal class action recoveries. These three pharmaceutical manufacturers supplied generic blood pressure medications containing NDMA impurities to distributors across Kansas, reaching patients through major pharmacy chains including CVS, Walgreens, and Walmart locations throughout the state. Kansas operates under a modified comparative negligence standard, which can affect how damages are calculated in pharmaceutical litigation. The state's statute of limitations for personal injury claims is typically two years, though class action settlements often have separate filing deadlines. Kansas residents must file claims within the court-approved deadline to participate in the settlement, and the state's Department of Health and Environment has tracked the recall of affected medications distributed to Kansas pharmacies between 2012 and 2018.

What medications are covered in the Aurobindo, Hetero, and Vivimed settlement for Kansas residents?

The $15.2 million settlement covers Valsartan, Losartan, and Irbesartan generic blood pressure medications manufactured by these companies and distributed to Kansas pharmacies. These medications contained NDMA impurities that were linked to increased cancer risk. Kansas residents who purchased these specific generic versions between 2012 and 2018 may be eligible for compensation.

How does Kansas law affect my ability to file additional claims against these pharmaceutical companies?

Kansas Consumer Protection Act may allow residents to pursue separate state law claims for deceptive practices beyond the federal class action settlement. However, participating in the class action settlement typically requires waiving rights to individual lawsuits. Kansas residents should consult with attorneys familiar with state pharmaceutical liability laws before deciding whether to opt out of the settlement.

Are there specific documentation requirements for Kansas residents filing claims in this settlement?

Kansas residents need pharmacy records, prescription bottles, or insurance records showing they purchased the affected Valsartan, Losartan, or Irbesartan medications from these manufacturers. The Kansas Board of Pharmacy maintains records that may help verify which generic versions were distributed to specific pharmacies during the relevant time period. Medical records showing related health issues may increase compensation amounts.

Tips for Kansas Residents Filing Aurobindo, Hetero, and Vivimed Claims

Kansas residents filing claims in the Aurobindo, Hetero, and Vivimed settlement should gather prescription records from all Kansas pharmacies where they filled affected medications. Contact your insurance company for prescription history if pharmacy records are unavailable. The Kansas Board of Pharmacy website provides manufacturer information that can help identify whether your specific generic blood pressure medication was produced by these companies. File claims before the court-approved deadline, as Kansas state law cannot extend federal class action filing periods. Consider consulting Kansas-licensed attorneys familiar with pharmaceutical settlements, as the state's consumer protection laws may provide additional remedies. Keep copies of all submitted documentation and track your claim status through the settlement administrator's website.

More Kansas Resources